← Back to Search

Behavioral Intervention

Delayed Feedback for Parkinson's Disease

Verified Trial
N/A
Recruiting
Led By Ekaterina Dobryakova, PhD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Only participants with scores above 24/30 on the Montreal Cognitive Assessment will be recruited for participation to exclude dementia.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up testing lasts 60 minutes and completed in 1 day
Awards & highlights

Study Summary

"This trial investigates how individuals with Parkinson's Disease learn from feedback. The study suggests that learning through delayed feedback, as opposed to immediate feedback, may lead to better learning outcomes for individuals with Parkinson's Disease

Who is the study for?
This trial is for individuals with Parkinson's Disease who can learn and remember well enough to score above 24/30 on a cognitive test called the Montreal Cognitive Assessment, which ensures they do not have dementia.Check my eligibility
What is being tested?
The study tests if people with Parkinson's Disease learn better when feedback is delayed. Participants take a multiple-choice test and receive feedback either immediately or after a 25-minute delay to see which method improves learning more.See study design
What are the potential side effects?
Since this trial involves only delayed feedback during a learning task, there are no direct medical side effects associated with the intervention being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~testing lasts 60 minutes and completed in 1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and testing lasts 60 minutes and completed in 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent correct responses will be collected through the computer software

Trial Design

1Treatment groups
Experimental Treatment
Group I: Parkinson DiseaseExperimental Treatment1 Intervention
Participants with Parkinson Disease; Single group.

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
174 Previous Clinical Trials
10,698 Total Patients Enrolled
Ekaterina Dobryakova, PhDPrincipal InvestigatorKessler Foundation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing opportunities for patients to participate in this research study?

"Yes, data from clinicaltrials.gov shows that recruitment for this trial is ongoing. The trial was initially posted on September 1st, 2023 and last modified on January 19th, 2024. It aims to enroll a total of 40 participants at one location."

Answered by AI

How many individuals are currently enrolled as participants in this clinical trial?

"Affirmative, information available on clinicaltrials.gov indicates that this specific clinical trial is presently in the process of enrolling participants. The trial was initially uploaded on September 1st, 2023 and last revised on January 19th, 2024. Recruitment aims to include a total of 40 patients from one designated site."

Answered by AI

Who else is applying?

What site did they apply to?
Kessler Foundation
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

Why did patients apply to this trial?

I wanted to try out other ways to get cured. I have Parkinsons and would like for a cure to be found.
PatientReceived no prior treatments
I want to be able to stop the progression of this disease. I HAVE NOT BEEN ON DRUGS YET THAT IS GOING TO HAPEN SHORTLY.
PatientReceived no prior treatments
I am looking for medication that can help me without costing a fortune.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. Kessler Foundation: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease
Ekaterina Dobryakova 2023. "Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06217484.
~27 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top